Showing 1 - 10 of 38
Persistent link: https://www.econbiz.de/10011537364
Objective. To understand whether US and Canadian breast, colorectal and prostate cancer screening test utilization is consistent with US and Canadian cancer screening guideline information with respect to the age of screening initiation. Design. Cross-sectional, regression discontinuity....
Persistent link: https://www.econbiz.de/10014178454
U.S. cancer screening guidelines recommend that cancer screening begin for breast cancer at age 40 and for colorectal cancer and prostate cancers at age 50. What are the marginal returns to physician and individual compliance with these cancer screening guidelines? We estimate the marginal...
Persistent link: https://www.econbiz.de/10014179658
Background: Cancer screening guidelines reflect the costs and benefits of population-based screening based on evidence from clinical trials. While most of the existing literature on compliance with cancer screening guidelines only measures raw screening rates in the target age groups, we used a...
Persistent link: https://www.econbiz.de/10014192650
Persistent link: https://www.econbiz.de/10009260196
Persistent link: https://www.econbiz.de/10010216630
This paper develops a new method for estimating trends in the size of counterfeit markets. The method draws on principles of microeconomic theory and uses aggregated product-level data to estimate counterfeiting activities in various geographic markets. Using confidential firm unit forecasts and...
Persistent link: https://www.econbiz.de/10010553383
Persistent link: https://www.econbiz.de/10009562243
Persistent link: https://www.econbiz.de/10003965336
Persistent link: https://www.econbiz.de/10011817628